SEK299.00
0.00% today
Stockholm, Apr 29, 05:29 pm CET
ISIN
SE0009858152
Symbol
BONEX
Sector

Bonesupport Holding AB Stock price

SEK299.00
-0.60 0.20% 1M
-24.20 7.49% 6M
-87.80 22.70% YTD
+72.20 31.83% 1Y
+260.80 682.72% 3Y
+264.60 769.19% 5Y
+267.00 834.38% 10Y
Stockholm, Closing price Mon, Apr 28 2025
-18.40 5.80%
ISIN
SE0009858152
Symbol
BONEX
Sector

Key metrics

Market capitalization SEK19.69b
Enterprise Value SEK19.44b
P/E (TTM) P/E ratio 160.80
EV/FCF (TTM) EV/FCF 206.61
EV/Sales (TTM) EV/Sales 19.48
P/S ratio (TTM) P/S ratio 19.73
P/B ratio (TTM) P/B ratio 26.58
Revenue growth (TTM) Revenue growth 52.17%
Revenue (TTM) Revenue SEK997.85m
EBIT (operating result TTM) EBIT SEK181.17m
Free Cash Flow (TTM) Free Cash Flow SEK94.08m
Cash position SEK267.14m
EPS (TTM) EPS SEK1.86
P/E forward 89.32
P/S forward 15.55
EV/Sales forward 15.35
Show more

Is Bonesupport Holding AB a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Bonesupport Holding AB Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a Bonesupport Holding AB forecast:

3x Buy
75%
1x Hold
25%

Analyst Opinions

4 Analysts have issued a Bonesupport Holding AB forecast:

Buy
75%
Hold
25%

Financial data from Bonesupport Holding AB

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
998 998
52% 52%
100%
- Direct Costs 74 74
41% 41%
7%
924 924
53% 53%
93%
- Selling and Administrative Expenses 657 657
32% 32%
66%
- Research and Development Expense 86 86
46% 46%
9%
190 190
241% 241%
19%
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 181 181
291% 291%
18%
Net Profit 122 122
54% 54%
12%

In millions SEK.

Don't miss a Thing! We will send you all news about Bonesupport Holding AB directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

BONESUPPORT HOLDING AB engages in the development and commercialization of injectable bioceramic bone graft substitutes to treat bone voids. It markets its products through its propriety CERAMENT technology platform. The firm's products focuses on the treatment of trauma, revision arthro-plasty, chronic osteomyelitis, and foot infections and ankle surgery. It operates through the North America, and Europe and Rest of the World geographical segments. The company was founded by Lars Åke Alvar Lidgren and Fredrik Lindberg in 1999 and is headquartered in Lund, Sweden.

Head office Sweden
CEO Emil Billbäck
Employees 139
Founded 2010
Website www.bonesupport.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today